Cantor Fitzgerald Trims Humana (NYSE:HUM) Target Price to $360.00

Humana (NYSE:HUM) had its price target trimmed by Cantor Fitzgerald from $391.00 to $360.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have a neutral rating on the insurance provider’s stock. Cantor Fitzgerald also issued estimates for Humana’s FY2024 earnings at $16.04 EPS.

Several other research analysts have also issued reports on the stock. Barclays cut their target price on shares of Humana from $356.00 to $310.00 and set an equal weight rating for the company in a research report on Tuesday, April 2nd. Oppenheimer cut their price target on shares of Humana from $415.00 to $370.00 and set an outperform rating for the company in a research report on Thursday. Bank of America restated a neutral rating and set a $342.00 price target (down from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Royal Bank of Canada cut their price target on shares of Humana from $507.00 to $415.00 and set an outperform rating for the company in a research report on Friday, January 26th. Finally, Wells Fargo & Company cut their price target on shares of Humana from $413.00 to $350.00 and set an overweight rating for the company in a research report on Monday, April 8th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of Hold and a consensus price target of $424.50.

Humana Stock Down 1.8 %

Shares of NYSE:HUM opened at $305.90 on Thursday. Humana has a 52-week low of $299.23 and a 52-week high of $541.21. The firm has a fifty day moving average of $327.77 and a 200 day moving average of $393.91. The firm has a market capitalization of $36.86 billion, a PE ratio of 19.05, a price-to-earnings-growth ratio of 1.79 and a beta of 0.45. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.59 and a current ratio of 1.67.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same period in the previous year, the business earned $9.38 earnings per share. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year. As a group, research analysts anticipate that Humana will post 16.08 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is 22.04%.

Insider Activity

In other news, Director Jorge S. Mesquita acquired 545 shares of the stock in a transaction dated Tuesday, February 20th. The stock was purchased at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.32% of the company’s stock.

Hedge Funds Weigh In On Humana

Institutional investors have recently bought and sold shares of the stock. Rakuten Securities Inc. bought a new position in Humana in the fourth quarter worth about $25,000. Gradient Investments LLC raised its stake in Humana by 200.0% in the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after buying an additional 40 shares in the last quarter. Cetera Trust Company N.A bought a new position in Humana in the fourth quarter worth about $28,000. Private Wealth Management Group LLC bought a new position in Humana in the fourth quarter worth about $32,000. Finally, Nvwm LLC raised its stake in Humana by 41.0% in the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after buying an additional 25 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.